Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Blood Advances|March 21, 2024
Therapy-related chronic myelomonocytic leukemia does not have the high-risk features of a therapy-related neoplasmAlex Bataller, Georgina Gener-Ricos, Emmanuel Almanza-Huante, et al.
Leukemia Research|February 12, 2025
Characteristics and survival outcomes of patients with myelodysplastic syndromes with isolated 11q deletionKensuke Takaoka, Rami Komrokji, Kelly Chien, et al.
Nature Communications|March 19, 2024
Hematopoietic stem cells with granulo-monocytic differentiation state overcome venetoclax sensitivity in patients with myelodysplastic syndromesJuan Jose Rodriguez-Sevilla, Irene Ganan-Gomez, Feiyang Ma, et al.
Cancer|June 19, 2024
NPM1-mutated myeloid neoplasms are a unique entity not defined by bone marrow blast percentageGeorgina Gener-Ricos, Alex Bataller, Juan Jose Rodriguez-Sevilla, et al.
Leukemia Research|August 23, 2024
Characteristics and outcomes of children, adolescent, and young adult patients with myelodysplastic neoplasms: A single-center retrospective analysisDavid McCall, Tareq Abuasab, Juan Jose Rodriguez-Sevilla, et al.
Cell Reports. Medicine|May 23, 2024
Targeting MCL1-driven anti-apoptotic pathways overcomes blast progression after hypomethylating agent failure in chronic myelomonocytic leukemiaGuillermo Montalban-Bravo, Natthakan Thongon, Juan Jose Rodriguez-Sevilla, et al.
Biorxiv : the Preprint Server for Biology|October 9, 2023
IL-1β-mediated inflammatory signaling drives ineffective erythropoiesis in early-stage myelodysplastic syndromesVera Adema, Irene Ganan-Gomez, Feiyang Ma, et al.
British Journal of Haematology|August 23, 2023
Phenotypic subtypes of leukaemic transformation in chronic myelomonocytic leukaemiaGuillermo Montalban-Bravo, Rashmi Kanagal-Shamanna, Ziyi Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 2024
Cytogenetic and Molecular Associations with Outcomes in Higher-Risk Myelodysplastic Syndromes Treated with Hypomethylating Agents plus VenetoclaxAlexandre Bazinet, Sai Prasad Desikan, Ziyi Li, et al.
Hemasphere|January 30, 2026
Unveiling relative lymphopenia and elevated monocyte-to-lymphocyte count as novel independent adverse prognostic factors in chronic myelomonocytic leukemia (CMML)-Proposal of the objective prognostic index for CMML (OPIC)Xavier Calvo, Abora Rial-Villavecchia, David Roman-Bravo, et al.
Pageof 3